The law firm of Nachawati Law Group is currently taking cases for individuals who have suffered injuries due to Digitek, also known as Digoxin. Recently, a drug manufacturer, Actavis Totowa LLC, a United States manufacturing division of the international generic pharmaceutical company Actavis Group, has initiated a Class I nationwide recall of Digitek (digoxin tablets, USP, all strengths) intended for oral use. The products are distributed by Mylan Pharmaceuticals Inc., under a “Bertek” label and by UDL Laboratories, Inc. under a “UDL” label. Actavis manufactures the products for Mylan and the products are distributed by Mylan and UDL under the Bertek and UDL labels. Bertek and UDL are affiliates of Mylan.
The nationwide recall is due to the possibility that tablets with double the appropriate thickness may have been commercially released. These tablets may contain twice the approved level of active ingredient than it appropriate.
Digitek is used to treat heart failure and abnormal heart rhythms. The existence of double strength tablets poses a risk of digitalis toxicity in patients with renal failure. Digitalis toxicity can cause nausea, vomiting, dizziness, low blood pressure, diarrhea, excessive urination, low blood pressure, swelling, abnormally slow heartbeat, heart palpitations, loss of appetite, cardiac instability and bradycardia. Death can also result from excessive Digitalis intake. Several reports of illnesses and injuries have been received.
———
About Nachawati Law Group
Nachawati Law Group represents parties in mass tort litigation, businesses and governmental entities in contingent litigation, and individuals in complex personal injury litigation. For more information, visit contact or call 214-890-0711.
